Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurexophilin and PC-esterase domain family member 3 (NXPE3) is a protein-coding gene encoding a neuropeptide-like glycoprotein in the neurexophilin family. The protein contains a variable N-terminal domain, a highly conserved central neurexophilin and PC-esterase (NXPE) domain, a short linker region, and a cysteine-rich C-terminal domain. NXPE3 binds alpha neurexins, which are presynaptic transmembrane receptors involved in promoting adhesion between dendrites and axons. Alternative splicing results in multiple transcript variants, but the precise biological functions and disease associations of the protein are yet to be experimentally confirmed[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurexophilin and PC-esterase domain family member 3 (NXPE3).